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Abstract
Background: As the primary resident immune cells, microglia play a central role in regulating inflammatory
processes in the CNS. The extracellular matrix (ECM) protein vitronectin promotes microglial activation, switching
microglia into an activated phenotype. We have shown previously that microglia express two vitronectin receptors,
avb3 and avb5 integrins. As these integrins have well-defined roles in activation and phagocytic processes in
other cell types, the purpose of the current study was to investigate the contribution of these two integrins in
microglial activation.
Methods: Microglial cells were prepared from wild-type, b3 integrin knockout (KO), b5 integrin KO or b3/b5
integrin DKO mice, and their interactions and activation responses to vitronectin examined in a battery of assays,
including adhesion, expression of activation markers, MMP-9 expression, and phagocytosis. Expression of other av
integrins was examined by flow cytometry and immunoprecipitation.
Results: Surprisingly, when cultured on vitronectin, microglia from the different knockout strains showed no obvious
defects in adhesion, activation marker expression, MMP-9 induction, or phagocytosis of vitronectin-coated beads. To
investigate the reason for this lack of effect, we examined the expression of other av integrins. Flow cytometry showed
that b3/b5 integrin DKO microglia expressed residual av integrin at the cell surface, and immunoprecipitation
confirmed this finding by revealing the presence of low levels of the avb1a n davb8 integrins. b1 integrin blockade
had no impact on adhesion of b3/b5 integrin DKO microglia to vitronectin, suggesting that in addition to avb1, avb3,
and avb5, avb8 also serves as a functional vitronectin receptor on microglia.
Conclusions: Taken together, this demonstrates that the avb3 and avb5 integrins are not essential for mediating
microglial activation responses to vitronectin, but that microglia use multiple redundant receptors to mediate
interactions with this ECM protein.
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Background
Microglia are immune effector cells resident in the cen-
tral nervous system (CNS), whose main role is to
orchestrate immunological responses following cerebral
insults [1-3]. In the resting CNS, microglia occupy a
basal surveillance state, but after activation by pro-
inflammatory cytokines or microorganisms, they trans-
form into metabolically active phagocytic cells, upregu-
lating expression of cytokines and chemokines, and
migrating to the inflammatory focus. As well as playing
a protective role, recent evidence suggests that in some
diseases, including multiple sclerosis (MS), microglia
may become inappropriately stimulated, leading to auto-
immune destruction of host tissue [4-7].
To understand why microglia may become inappropri-
ately activated in the early stages of MS, we have
focused our attention on the function of certain ECM
proteins present in blood at high concentrations, includ-
ing fibronectin and vitronectin [8,9]. We have demon-
strated that the plasma proteins vitronectin and
fibronectin promote microglial activation in vitro
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brain barrier (BBB) breakdown is an early event in the
pathogenesis of MS we proposed that leakage of these
two proteins into brain parenchymal tissue pre-disposes
to microglial activation and myelin damage. Results
obtained with the experimental autoimmune encephalo-
myelitis (EAE) model demonstrated that BBB break-
down was closely associated with fibronectin and
vitronectin deposits in the CNS, which closely correlated
with microglial activation and expression of the matrix
metalloproteinase, MMP-9 [11]. Combined with the evi-
dence from other groups demonstrating vitronectin and
fibronectin deposition in demyelinated lesions in the
brains of MS patients [12-14] and EAE mice [15], this
supports the hypothesis that fibronectin and vitronectin
promote microglial activation in vivo.
A major question yet to be fully answered is: which
microglial receptors mediate the activation response to
vitronectin? Our prior work has shown that microglia
express the two vitronectin receptors, avb3a n davb5
integrins, and that the microglial response to vitronectin
is largely mediated by avi n t e g r i n s[ 1 1 ] .A st h eavb3
and avb5 integrins have well-defined roles in activation
and phagocytic processes in other cell types, the purpose
of the current study was to investigate the contribution
of these two integrins in this process, and thereby test
our hypothesis that absence of both avb3a n davb5
integrins would render microglia unresponsive to vitro-
nectin. To examine these events, microglial cells were
prepared from wild-type, b3i n t e g r i nK O ,b5i n t e g r i n
KO and b3/b5 integrin DKO mice, and the behavior of
these microglia evaluated in a battery of assays including
cell adhesion, expression of activation markers and
MMP-9, and phagocytosis of vitronectin-coated beads.
Methods
Animals
The studies described have been reviewed and approved
by The Scripps Research Institute Institutional Animal
Care and Use Committee. b3 integrin KO and b5 integ-
rin KO mice (backcrossed > 10 times on the C57Bl/6
background) were maintained under pathogen-free con-
ditions in the closed breeding colony of The Scripps
Research Institute (TSRI). b3 integrin KO and b5i n t e g -
rin KO mice were bred and offspring genotyped using
previously described protocols [16-19] to generate
homozygous b3i n t e g r i nK O( b3 -/-), homozygous b5
integrin KO (b5 -/-), and double-knockout (DKO) mice,
homozygous (b3- / - ,b5 -/-). In all experiments, litter-
mate wild-type mice were used as controls.
Cell culture
Pure cultures of mouse microglia were obtained as
described previously [20], with cultures from the
different strains of mice being established at the same
time in parallel. Briefly, 7-10 day old mixed glial cultures
were shaken for 30 minutes and the supernatant con-
taining detached microglia was collected. Microglia were
counted by hemocytometer and plated at a density of 2
×1 0
5 cells/well in six-well plates (Nunc, Naperville, IL)
previously coated for two hours at 37°C with a 10 μg/ml
solution of vitronectin (Sigma). Cells were grown over-
n i g h ti nt h em i x e dg l i a lc u l t u r em e d i a ,a n dt h e n
switched to N1 serum-fee media (DMEM supplemented
with N1 (Sigma). The purity of these microglial cultures
w a s>9 9 %a sd e t e r m i n e db yM ac-1 positivity in flow
cytometry.
Cell adhesion assays
Adhesion assays were performed as previously described
[20]. Briefly, substrates were prepared by coating the
central area of 24 well plates (Nunc) with 25 μlo fE C M
solution (10 μg/ml of vitronectin or fibronectin, both
from Sigma) for 2 hours at 37°C. Substrates were
washed twice before addition of cells. Microglia were
prepared as described above, centrifuged, re-suspended
in N1 serum-free media, and 2000 microglia applied to
the substrates in a 25 μl drop and then incubated at 37°
C for 15 or 30 minutes. In the function-blocking experi-
ments, the anti-av monoclonal antibody (RMV-7), anti-
b1 monoclonal antibody (Ha2/5) or control antibodies
were included at a concentration of 5 μg/ml. The assay
was stopped by adding 1 ml of DMEM and washing off
any loosely attached cells. The attached cells were fixed
in 4% paraformaldehyde in PBS for 20 minutes, and
stored in PBS. Adhesion was quantified under phase
microscopy by counting all attached cells within 5 fields
of view per condition. Within each experiment each
condition/time-point was performed in duplicate; the
results represent the mean ± SEM of three experiments.
Statistical significance was assessed by using the Stu-
dent’s paired t test, in which p < 0.05 was defined as
statistically significant.
Antibodies
The following monoclonal antibodies were obtained
from BD Pharmingen (La Joll a ,C A ) :r a tm o n o c l o n a l
antibodies reactive for MHC class I (M1/42.3.9.8), the
integrin subunits a4( M F R 4 . B ) ,a5 (5H10-27 (MFR5)),
av (RMV-7), aM (M1/70), and the isotype control anti-
body, rat anti-KLH (A110-2), and the hamster monoclo-
nal antibodies reactive for the b1(Ha2/5; function-
blocking antibody) and b3 (2C9.G2) integrin subunits
and isotype control (G235-1). Rabbit polyclonal antibo-
dies specific for the av integrin subunit were obtained
from Chemicon (Temecula, CA). The anti-b8i n t e g r i n
polyclonal antibody was a kind gift from Dr. Joseph
McCarty, M.D. Anderson Cancer Center, Houston, TX.
Welser-Alves et al. Journal of Neuroinflammation 2011, 8:157
http://www.jneuroinflammation.com/content/8/1/157
Page 2 of 10Cell surface labeling and immunoprecipitation
Microglial cell surface molecules were labeled with bio-
tin as previously described [10,21]. Briefly, microglial
cell cultures were incubated with NHS-LC-biotin
(Pierce, Rockford, IL) for 30 minutes, washed in TRIS-
containing cell wash buffer (CWB), and then removed
from tissue culture plates and centrifuged. Cells were
l y s e di n0 . 5 %T r i t o n - X 1 0 0i nC W Bt h a tc o n t a i n e da
cocktail of protease inhibitors (Invitrogen, Carlsbad,
CA). After 30 minutes on ice, the lysate was centrifuged
to remove the insoluble fraction. The supernatants were
pre-cleared for one hour with 30 μl of protein A sephar-
ose or protein G sepharose per ml of cell lysate. Immu-
noprecipitations were performed overnight at 4°C on a
rotating platform using the polyclonal anti-av or anti-b8
integrin antibodies at 1:250 dilution in a tube containing
30 μl protein A sepharose. Beads were washed 5 times
in immunoprecipitation wash buffer, as previously
described and the integrin immune complexes were
separated by boiling the beads in non-reducing sample
buffer for 5 minutes before being analysed by 8% SDS-
PAGE (Invitrogen) under non-reducing conditions. Pro-
teins were electro-blotted for 1.5 hours onto nitrocellu-
lose membranes (Invitrogen), blocked overnight in 3%
BSA in TBS containing 0.1% Tween-20 (Sigma) and
probed with streptavidin-HRP conjugate (Pierce) for one
hour, before being extensively washed. Protein bands
were visualised with the SuperSignal WestFemto ECL
detection system (Pierce) according to the manufac-
turers’ instructions.
Microglial phagocytosis of vitronectin-coated beads
Microglial cells were plated at a density of 2 × 10
5 cells/
well in six-well plates. After one day of culture, 2.5 μlo f
a suspension of yellow-green fluorescent beads (Molecu-
lar Probes, Eugene, OR) previously coated in a 100 μg/
ml vitronectin solution for 2 hours at 37°C, was added
to the microglia, and thoroughly mixed with the tissue
culture media to distribute the beads throughout the
culture. After a further 24 hours, cultures were visua-
lised for microglial uptake of beads, and microglia col-
lected and phagocytic uptake of fluorescent beads
analyzed by flow cyometry, with 10,000 events recorded
for each condition. The phagocytic index of microglia
was quantified and expressed as the mean fluorescent
intensity of the cell population. Each experiment was
repeated a minimum number of four times and the data
expressed as mean ± SD. Statistical significance was
assessed by using the Student’s paired t test, in which p
< 0.05 was defined as statistically significant.
Flow cytometry
Microglia, isolated from the four different strains of
mice, were cultured in vitronectin-coated 6-well plates
under serum-free conditions. After 2 days, microglia
were removed from the culture plates and cell surface
expression of MHC class I and the integrins a4, a5, av
or Mac-1 analyzed by flow cytometry using direct fluor-
escent-conjugated monoclonal antibodies, as described
previously [20]. The fluorescent intensity of the labeled
cells was analyzed with a Becton Dickinson FACScan
machine (San Diego, CA), with 10,000 events recorded
for each condition. For each experimental condition, the
mean fluorescent intensity was compared with the con-
trol state and expressed as the percentage change rela-
tive to the control condition. Each experiment was
repeated a minimum number of four times and the data
expressed as mean ± SD. Statistical significance was
assessed by using the Student’s paired t test, in which p
< 0.05 was defined as statistically significant.
Gel zymography
Gelatin zymography was used to detect MMP-9 activity
as previously described [11,22]. Microglial cells were
plated at a density of 2 × 10
5 cells/well in six-well plates
that were either left uncoated, or coated with vitronectin
or fibronectin. After 2 days culture, microglial superna-
tants were collected and analyzed for gelatinolytic activ-
ity. Positive controls for MMP-9 and MMP-2 (obtained
from R&D) were included. For quantification, gels were
scanned using a Bio-Rad VersaDoc imaging system
(Hercules, CA) and band intensities quantified using the
NIH Image program. Each experiment was repeated a
minimum number of four times and the data expressed
as mean ± SD. Statistical significance was assessed by
using the Student’s paired t test, in which p < 0.05 was
defined as statistically significant.
Results
Absence of avb3, avb5, or both integrins does not
diminish microglial adhesion to vitronectin
Vitronectin is a strong inducer of microglial activation,
and antibody-blocking studies have demonstrated that
this effect is mediated primarily via av integrins [11].
Microglia express high levels of the two vitronectin
receptors, avb3a n davb5i n t e g r i n s[ 2 3 ] ,w h i c hh a v e
well-defined roles in activation and phagocytic processes
in other cell types [24,25]. The purpose of the current
study was to investigate the contributions of the avb3
and avb5 integrins to this process, and test our hypoth-
esis that absence of both these integrins would render
microglia unresponsive to vitronectin. To examine these
events, mixed glial cultures (MGC) were established
from postnatal brains of four different strains of mice:
wild-type, b3i n t e g r i nK O ,b5i n t e g r i nK Oa n db3/b5
integrin DKO. In the first set of experiments, we exam-
i n e dt h er o l eo fav integrins in mediating microglial
adhesion to vitronectin. In 30-minute adhesion assays,
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inhibited the adhesion of both wild-type microglia (from
847 ± 134 cells under control conditions to 157 ± 44
cells with av antibody, p < 0.005) and b3/b5i n t e g r i n
DKO microglia (from 822 ± 101 cells under control
conditions to 78 ± 39 cells with av antibody, p < 0.005)
to vitronectin (Figure 1A). This demonstrates that av
integrins are the major class of vitronectin receptors
that mediate microglial adhesion to vitronectin, confirm-
ing the findings from previous studies [11,20]. Next, we
examined whether microglia lacking the avb3o ravb5
integrins can attach to vitronectin. In short term adhe-
sion assays lasting 15 or 30 minutes, we detected no
defects in the attachment of any of the knockout strains
of microglia compared to wild-type cells (Figure 1B). In
addition, after 60 minutes of adhesion, there were no
obvious differences in the spreading characteristics or
morphology of the different strains (Figure 1C).
Microglial activation responses to vitronectin are not
affected by the absence of avb3, avb5 or both these
integrins
Microglial activation correlates with a morphological
switch from a phase-bright, process bearing cell to a
phase-dark amoeboid phenotype. In light of our finding
that b3K O ,b5K Oa n db3/b5D K Os h o wt h es a m e
morphological activation on vitronectin as wild-type
cells (Figure 1B), this suggests that the avb3a n davb5
integrins are not essential for mediating microglial
responses to vitronectin. However, to confirm changes
of microglial activation at the molecular level, we also
examined cell surface expression of the activation mar-
kers MHC class I, and the integrins, a4b1, a5b1a n d
aMb2 (Mac-1). Microglia were cultured on vitronectin
under serum-free conditions for 2 days, and their
expression levels of activation markers quantified by
flow cytometry (Figure 2). Consistent with previous
results [10], fibronectin and vitronectin stongly pro-
moted microglial expression of all the cell surface mar-
kers of activation, including MHC class I and the
different activation integrins. However, relative to wild-
type cells, microglia lacking b3, b5, or both integrins
showed no significant difference in their expression of
the activation markers MHC class I, or the integrins,
a4b1, a5b1, or Mac-1.
As vitronectin strongly promotes microglial expression
of the matrix metalloproteinase MMP-9 [11], we also
tested whether b3K O ,b5K Oo rb3/b5D K Om i c r o g l i a
were deficient in their expression of MMP-9 in response
to vitronectin. To quantify microglial expression of
MMP-9, gelatin zymography was performed on superna-
tants taken from microglia cultured under serum-free
conditions for three days on vitronectin. Consistent with
previous results, fibronectin and vitronectin promoted
strong induction of pro-MMP-9 compared to the
uncoated plastic control substrate (Figures 3A and 3B)
[11]. However, there were no significant differences in
the level of MMP-9 induction of any of the KO strains
of microglia cultured on vitronectin (or fibronectin),
compared with wild-type cells. Next, we evaluated
whether there were any defects in the ability of integrin-
deficient microglia to phagocytose vitronectin-coated
Figure 1 Evaluating the role of av integrins in mediating
microglial adhesion to vitronectin. A. Adhesion to vitronectin of
microglia derived from wild-type or b3/b5 integrin DKO mice in the
presence or absence of an anti-av blocking antibody was examined
as described in Materials and Methods. Adhesion is expressed as the
number of cells adherent within a given field of view after 30
minutes adhesion. All points represent the mean ± SEM of three
experiments. B. Time course of adhesion to vitronectin for microglia
derived from wild-type, b3 integrin KO, b5 integrin KO and b3/b5
integrin DKO mice. Adhesion is expressed as the number of cells
adherent within a given field of view, after 15 and 30 minutes of
cell adhesion. All points represent the mean ± SEM of three
experiments. C. Phase pictures of wild-type, b3 integrin KO, b5
integrin KO and b3/b5 integrin DKO mice microglia adherent to
vitronectin after 60 minutes. Scale bar = 50 μm. Note that none of
the KO strains showed defects in their adhesion to vitronectin.
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fluorescent beads for 24 hours, and the phagocytic
uptake of beads analyzed by flow cyometry. As shown in
Figure 3C, there were no differences in the phagocytic
activity of microglia derived from the different strains of
mice.
Microglia deficient in b3 and b5 integrins show low
expression levels of two additional av integrins
Unexpectedly, our experiments revealed that microglia
lacking the b3, b5 or both integrins show no defects in
their activation responses to vitronectin. As previous phar-
macological function-blocking experiments demonstrated
that av integrins are an important mediator of this
response [11], this suggests that microglia may express
additional av integrins to mediate this effect. To test this,
we performed flow cytometry on b3/b5 DKO microglia to
evaluate expression of the av integrin subunit. This
showed that b3/b5 DKO microglia express the av integrin
subunit, albeit at much-reduced levels, approximately 10-
15% that of wild-type cells (Figure 4A). To confirm this
finding, we next examined this at the biochemical level by
performing av immunoprecipitations on all four strains of
microglia: wild-type, b3 KO, b5 KO and b3/b5 DKO. The
advantage of this approach is that it reveals all the av
integrin heterodimers expressed by microglial cells, so as
well as addressing whether av integrin is expressed, it also
allows us to identify the different b integrin subunits that
associate with the av subunit. Microglia were cultured on
vitronectin under serum-free conditions for two days, then
cell surface molecules biotinylated and lysates prepared.
As shown in Figure 4B, wild-type microglia expressed the
av integrin subunit (140 kD) in association with high
levels of the b3 (80 kD) and b5 (90 kD) integrin subunits.
As expected, an av immunoprecipitation of b3 KO micro-
glia revealed only the av and b5 subunits, while one of b5
KO microglia revealed only the ava n db3 subunits. Signif-
icantly, an av immunoprecipitation of b3/b5 DKO micro-
glia showed that the av subunit was still present, albeit at
very low levels, in association with two different integrin b
subunits, with molecular weights of approximately 110
and 80 kD. Based on molecular weight, these can be iden-
tified as the b1a n db8 subunits, respectively [21,26,27].
Further immunoprecipitations with a b8 integrin-specific
Figure 2 Evaluating the role of the avb3 and avb5 integrins in promoting microglial activation state in response to vitronectin. Wild-
type, b3 integrin KO, b5 integrin KO and b3/b5 integrin DKO microglia were purified from mixed glial cultures as described in Materials and
Methods, and then cultured in serum-free medium on vitronectin. After two days in culture, microglial expression of the activation marker MHC
class I (panel A) or the a4, a5 and aM (Mac-1) integrin subunits (panel B) was analyzed by flow cytometry. All points in the graphs are
expressed as the mean fluorescent index (MFI), and represent the mean ± SEM of three experiments. Note that all four strains of microglia
expressed equivalent levels of the activation markers, implying that b3 integrin KO, b5 integrin KO and b3/b5 integrin DKO microglia had no
defect in their activation response to vitronectin.
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approximately 140 and 80 kD, corresponding to the av
and b8 subunits respectively, confirming b8 as the addi-
tional b subunit. Levels of microglial b8e x p r e s s i o nw e r e
not significantly different amongst the different strains of
mice (not shown). Thus, these biochemical results support
our flow cytometry observations, demonstrating that in
addition to avb3a n davb5, microglia also express low
levels of two additional avi n t e g r i n s ,avb1a n davb8.
The microglial avb8 integrin acts as a functional
vitronectin receptor, and avb3 is a functional fibronectin
receptor
While avb1 integrin is a well described functional vitro-
nectin receptor [28], it is less clear whether the avb8
integrin also fulfils this role. To investigate whether
avb8 is a functional vitronectin receptor in microglia,
we examined the effect of function-blocking anti-b1
integrin antibodies on microglial adhesion to vitronectin.
Under these conditions, the b3/b5 integrin DKO micro-
glia have only one potential av integrin available to
mediate adhesion to vitronectin, namely avb8. As
s h o w ni nF i g u r e5 ,i n3 0m i n u t ea d h e s i o na s s a y s ,b1
integrin blockade had no impact on the adhesion of
wild-type or b3/b5 integrin DKO microglia to vitronec-
tin. This shows that in the absence of avb1, avb3a n d
avb5 integrins, microglia can still attach to vitronectin,
suggesting that the avb8 integrin serves as a functional
vitronectin receptor on microglia. Interestingly, b1
integrin blockade revealed markedly different effects on
the ability of wild-type and b3/b5 integrin DKO micro-
glia to adhere to fibronectin. While the adhesion of
wild-type microglia was inhibited by approximately 50%
(from 523 ± 62 cells under control conditions to 278 ±
Figure 3 Examination of the role of the avb3 and avb5 integrins in mediating vitronectin induction of microglial activation. Wild-type,
b3 integrin KO, b5 integrin KO and b3/b5 integrin DKO microglia were purified from mixed glial cultures as described in Materials and Methods,
and then cultured in serum-free medium on uncoated plastic, fibronectin or vitronectin. After 2 days culture, levels of MMP-9 in the microglial
supernatants were examined by gel zymography. A. Representative gel zymogram. B. Summary of zymography experiments. Each point is
expressed as the percentage change in MMP-9 relative to control (wild-type microglia on uncoated plastic) and represents the mean ± SD of
three separate experiments. Note that culture on fibronectin and vitronectin increased MMP-9 expression in microglia from all strains of mice,
with no obvious differences detected between wild-type and integrin KO strains on any substrate. C. Examination of the role of the avb3 and
avb5 integrins in mediating microglial phagocytosis. Microglia from all 4 strains were purified as described in Materials and Methods, and
cultured in serum-free medium on uncoated plastic for 24 hours before 2 μl of vitronectin-coated yellow-green fluorescent 2 μm beads were
added to the cultures. 24 hours later cultures were washed to remove undigested beads and the microglial uptake of fluorescent beads
examined by flow cytometry. Each point is expressed as the mean fluorescent index of the microglial population, and represents the mean ± SD
of three experiments. Note that none of the integrin null microglia showed defects in their ability to phagocytose vitronectin-coated beads.
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sion of b3/b5 integrin DKO microglia to fibronectin was
i n h i b i t e db ym o r et h a n8 0 %( f r o m5 4 3±4 5c e l l su n d e r
control conditions to 102 ± 25 cells with the anti-b1
antibody, p < 0.005). Direct comparison of the effect of
b1 integrin blockade on wild-type or b3/b5i n t e g r i n
DKO microglia adhesion to fibronectin was found to be
statistically significant (p < 0.005). That b1i n t e g r i n
blockade only partially inhibits WT microglial adhesion
to fibronectin suggests that microglia use other recep-
tors to adhere to this substrate. As b1 integrin blockade
is much more effective at blocking the adhesion of b3/
b5 integrin DKO microglia to fibronectin, relative to
wild-type cells, this suggests that the avb3o ravb5
integrins may also act as fibronectin receptors. To deter-
mine the role of the avb3o ravb5i n t e g r i n si nm i c r o -
glial adhesion to fibronectin, we next examined the
effect of b1 integrin blockade on the four different
strains of microglia (Figure 5B). This showed that b1
Figure 4 Characterization of avi n t e g r i ne x p r e s s i o no n
microglia derived from wild-type, b3 integrin KO, b5 integrin
KO and b3/b5 integrin DKO mice. A. Flow cytometry analysis on
microglia derived from wild-type or b3/b5 integrin DKO mice.
Microglia were purified from mixed glial cultures as described in
Materials and Methods, and then cultured in serum-free medium on
vitronectin. After two days in culture, microglial expression of the
av integrin subunit was analyzed by flow cytometry. Note that b3/
b5 integrin DKO mice microglia express the av integrin subunit,
though at much reduced levels compared to wild-type cells. B.
Biochemical analysis. An av integrin imunoprecipitation of wild-type
microglia revealed a pattern of three bands: av (140 kD), b5 (90 kD)
and b3 (80 kD). As expected, av imunoprecipitations of b3K O
microglia showed only two dominant bands: av and b5, while that
on b5 KO microglia showed only two dominant bands: av and b3.
Significantly, av imunoprecipitations of b3/b5 DKO microglia
showed that the av subunit was still present, though at much
reduced levels compared to wild-type cells, and in association with
weak levels of two b subunits running at the molecular weights of
110 and 80 kD, which correspond to b1 and b8 integrin subunits,
respectively. C. Confirmation that microglia express the avb8
integrin. Immunoprecipitations of DKO microglia with a b8 integrin
polyclonal antibody detected a pattern of two bands running at
140 kD and 80 KD, that co-migrate with the av and lower b
integrin subunit detected in the av immunoprecipitation. This
confirms that the extra 80 kD band expressed by microglia is the b8
integrin subunit.
Figure 5 Examination of the role of b1 integrins in mediating
microglial adhesion to vitronectin or fibronectin. A. Adhesion to
vitronectin or fibronectin of microglia derived from wild-type or b3/
b5 integrin DKO mice was examined in the presence of a b1
integrin function-blocking antibody. Adhesion is expressed as the
number of cells adherent within a given field of view after 30
minutes of cell adhesion. All points represent the mean ± SEM of
three experiments. Note that b1 integrin blockade had no impact
on the adhesion of wild-type or b3/b5 integrin DKO microglia to
vitronectin, but that it inhibited microglial adhesion to fibronectin
by approximately 50% (wild-type) or greater than 80% (DKO). B.
Adhesion to fibronectin of microglia derived from wild-type, b3 KO,
b5K Oo rb3/b5 integrin DKO mice was examined in the presence
of a b1 integrin function-blocking antibody. Note that b1 integrin
blockade of wild-type or b5 integrin KO microglia resulted in
approximately 50% inhibition of adhesion to fibronectin, but in b3
integrin null or DKO microglia, the inhibition was greater than 80%.
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tion of adhesion to fibronectin of wild-type (from 740 ±
123 cells to 398 ± 79 cells with anti-b1a n t i b o d y ,p<
0.02), or b5 integrin null microglia (from 778 ± 69 cells
to 355 ± 67 cells with anti-b1a n t i b o d y ,p<0 . 0 1 ) ,b u t
greater than 80% inhibition in b3i n t e g r i nn u l l( f r o m
713 ± 116 cells to 126 ± 41 cells with anti-b1 antibody,
p < 0.005) or DKO microglia (from 733 ± 112 cells to
123 ± 61 cells with anti-b1 antibody, p < 0.005). Taken
together, this suggests that the avb3i n t e g r i n ,b u tn o t
the avb5 integrin, makes a significant contribution to
microglial adhesion to fibronectin.
Discussion
Microglia play a critical role in the CNS by performing
immune surveillance and regulating inflammatory pro-
cesses [1,2], therefore defining the factors that control
microglial activation state is of fundamental importance.
Evidence suggests that ECM proteins play an important
role in this process. In particular, vitronectin, present at
high levels in plasma [8], and absent in the normal CNS,
is deposited in a perivascular manner in MS tissue [13]
and in the mouse model of MS, EAE [11,15]. Consistent
with this, we have shown that vitronectin directly pro-
motes microglial activation in vitro [10,11]. The next
important question is to identify the microglial receptors
that mediate this effect. Having shown previously that
microglia express the two vitronectin receptors, avb3
and avb5 integrins [10,23], the purpose of the current
study was to investigate the contribution of these two
integrins in microglial activation, and thereby test our
hypothesis that absence of both avb3a n davb5 integrins
would render microglia unresponsive to vitronectin.
Using microglia derived from different strains of mice
(wild-type, b3i n t e g r i nK O ,b5 integrin KO and b3/b5
integrin DKO), different aspects of microglial activation
were examined. Surprisingly, when cultured on vitronec-
tin, microglia from the knockout strains showed no
obvious defects in adhesion, activation marker or MMP-
9 expression, or phagocytosis of vitronectin-coated beads.
To investigate the reason for this lack of effect, we exam-
ined the expression of other av integrins. This revealed
that microglia also express low levels of the alternative
vitronectin receptors, avb1a n davb8i n t e g r i n s .T h i s
demonstrates that the avb3a n davb5 integrins are not
essential for mediating microglial activation responses to
vitronectin, but that microglia use multiple redundant
receptors to mediate interactions with this ECM protein.
Non-essential roles for the avb3 and avb5 integrins in
microglial activation
Evidence gathered from a variety of different cell types
s u p p o r t sar o l ef o rt h eavb3a n davb5i n t e g r i n si np r o -
moting cellular activation and phagocytic responses. The
avb3 integrin has been implicated in mediating phagocy-
tosis in monocytes and peripheral macrophages, and the
avb5 integrin plays a similar role in macrophages and in
retinal pigment epithelial (RPE) cells [24,25,29]. Indeed, b5
KO mice develop accelerated age-related blindness as a
result of defective phagocytic clearance of old photorecep-
tor cells in the retina [19]. In addition, avb3 plays an
essential role in osteoclast function, supported by the fact
that osteoclasts in b3 KO mice have defective bone resorp-
tion [30]. With this in mind, we were surprised to find that
microglia lacking avb3a n davb5 integrins showed normal
adhesion and activation responses to vitronectin, and is
further demonstration that the findings of pharmacologi-
cal blockade studies are not always borne out by the use of
genetic KO approaches. This is perhaps best illustrated by
the case of the role of avb3a n davb5 integrins in promot-
ing angiogenesis, in which antibody blockade suggested
key roles for these integrins in angiogenesis [31,32], but
mice lacking these integrins display no apparent angio-
genic defect [16], actually displaying an enhanced angio-
genic response in tumor growth [33].
Redundancy of microglial av integrins
Our data show that the avb3a n davb5 integrins com-
prise the major fraction of total av integrins expressed
by microglia. However, we have found that microglia
also express two other vitronectin receptors, the avb1
and avb8 integrins, though at appreciably lower levels
than avb3a n davb5. What is surprising about our data
is that despite lacking the two abundant vitronectin
receptors, b3/b5 DKO microglia show no obvious
defects in adhesion to vitronectin, or in the subsequent
activation responses. This is in stark contrast to our
finding with brain endothelial cells, where absence of
the avb3 integrin leaves the cells totally unable to attach
to vitronectin [34]. This clearly demonstrates that the
avb3a n davb5 integrins are not essential for mediating
microglial activation responses to vitronectin, highlight-
ing the redundancy of microglial vitronectin receptors.
In this light it is informative to compare the av integrin
expression profile of microglia with other CNS cell
types. Both neural stem cells and oligodendrocyte pre-
cursor cells also express the four av integrins expressed
by microglia, avb1, avb3, avb5a n davb8 [21,27,35],
and it is interesting to note that all three cell types have
the capacity to migrate considerable distances, even in
the adult CNS. In contrast, astrocytes, which are far less
motile, express only avb5a n davb8 [18], while brain
endothelial cells express just the avb3 integrin, and then
only when actively undergoing angiogenesis [34,36,37].
Regulation of av integrin heterodimer formation
Integrins comprise a family of ab heterodimers, com-
p o s e do f1 1d i f f e r e n ta and 9 different b subunits. In
Welser-Alves et al. Journal of Neuroinflammation 2011, 8:157
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ab heterodimers, in reality, only 24 heterodimers have
been identified [26]. We have shown that microglia
express four different avb heterodimers, with high levels
of avb3a n davb5, and much lower levels of avb1a n d
avb8. This begs the question: what regulates the cou-
pling and abundance of each of the different av hetero-
dimers? It has been previously suggested that the av
i n t e g r i ns u b u n i ti sp r o d u c e di ne x c e s s ,a n di t sc e l ls u r -
face appearance is limited by the transcription level of
the associated b subunits [38]. An alternative mechan-
ism would be that the av subunit is produced in a fixed
amount, and that loss of one or more b subunits (e.g.:
b3) would automatically lead to compensatory upregula-
tion of the other b subunits (e.g.: b8). Our data would
appear to support the first mechanism, because loss of
both of the major b subunits b3 and b5 in microglia did
not result in any compensatory upregulation of avb1o r
avb8; rather the total amount of the av integrin subunit
was massively reduced.
Conclusions
The aim of this study was to define the role of the avb3
and avb5 integrins im mediating microglial activation
responses to vitronectin. Microglia from b3, b5, or b3/
b5 knockout strains showed no defects in adhesion, acti-
vation marker expression, MMP-9 induction, or phago-
cytosis of vitronectin-coated beads. Flow cytometry and
biochemical analysis revealed that microglia also express
low levels of the alternative vitronectin receptors, avb1
and avb8 integrins. Taken together, we conclude that
the avb3a n davb5 integrins are not essential for med-
iating microglial activation responses to vitronectin, but
that microglia employ multiple receptor systems to
mediate interactions with vitronectin. On embarking on
these studies, we were hopeful that identification of a
single vitronectin receptor would lead to potential thera-
peutic targets for blocking microglial activation. The
outcome of the current study suggests that pinpoint tar-
geting of single av integrins will not be productive, but
rather a broad-spectrum blockade aimed at targeting all
av integrins is more likely to be successful.
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